1) posthepatitic
肝炎后
1.
Objective:To probe into the clinical therapeutic effectiveness of Heluoshugan capsules in the treatment of posthepatitic cirrhosis.
目的 :探讨和络舒肝胶囊对肝炎后肝硬化患者的临床疗效。
2) posthepatitic
肝炎后的
3) Post-transfusion hepatitis
输血后肝炎
1.
This article summarized influential factors and changes of virus of post-transfusion hepatitis in recent years.
本文综述了近年来输血后病毒性肝炎发生的病原变化及其影响因素,强调了按照国家法律,法规,采血部门严格筛查,供血单位规范生产,用血医院严把指征是防止输血后肝炎的重要强制性措施。
4) withdrawal hepatitis
停药后肝炎
1.
Objective: To study the clinical characteristics and the retherapy of lamivudine withdrawal hepatitis.
目的研究拉米夫定停药后肝炎的临床特点与再次治疗。
5) Posthepatitic cirrhosis
肝炎后肝硬化
1.
Introduce professor Zhou Xinyou s experience on treating posthepatitic cirrhosis;
周信有教授治疗肝炎后肝硬化经验介绍
2.
The clinical significance of telomerase in the tendency of posthepatitic cirrhosis into hepatoma;
端粒酶活性在肝炎后肝硬化恶变趋势中的意义
3.
ObjectiveTo investigate the formula for TCM syndrome pattern differentiation in patients with posthepatitic cirrhosis.
目的探索肝炎后肝硬化中医证候的证候判别模式。
6) cirrhosis after suffering from hepatitis
肝炎后肝硬变
1.
Especially the medicine is effective in the treatment of cirrhosis after suffering from hepatitis, indicating that while protecting live.
其中对肝炎后肝硬变作用明显，提示晶珠肝泰舒胶囊在保肝同时，还有一定抗肝纤维化作用。
补充资料：暴发型病毒性肝炎
暴发型病毒性肝炎
病名。病毒性肝炎类 型之一。详见该条。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条